Studies of clonal evolution in breast cancer patient-derived xenografts in mice analyzed at single-cell resolution21 show that 24% of the resulting tumors exhibit SETD1A gene amplification (Fig. 1a). This evidence concerns the gene SETD1A and breast carcinoma.